None listed
Conditions
Brief summary
This study will compare standard of care nasopharyngeal swab NAT results to the presence of SARS-CoV-2 IgG, IgA and IgM antibodies approximately 14 days after initial onset of symptoms in intermediate/high risk participants presenting to the Albury Wodonga Health Coronavirus Clinic.
Interventions
Coronovirus Screening Clinic Participants
Participants have SARS-CoV-2 IgG, IgA and IgM antibody serum sample analysed approximately 14 days after developing Coronavirus symptoms. Upon completion of blood sampling, no further follow up is required. Data to be collected for the study will include general patient demographics, medical history, baseline SARS-CoV-2 NAT pathology results, SARS-CoV-2 Risk assessment and symptom assessment.
Sponsors
Albury Wodonga Health
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
• Participants aged 18 years or over • Participants who have attended Albury-Wodonga Health Coronavirus Screening clinic and have had a NP swab collected for SARS-CoV-2 NAT .• Both participants that have returned a negative or a positive swab will be included in the study. • Participants must be accessible for follow up testing • Able to read, write and understand English Participant Information and Consent Form • Signed Participant Information and Consent Form
Exclusion criteria
• Participants under 18 years of age • Unwilling to be contacted for follow up testing • Medical or psychiatric condition or occupational responsibilities that may preclude compliance with the protocol • Research study personnel as identified in this Protocol
Outcome results
None listed